Literature DB >> 18762240

Altered gene expression and function of peripheral blood natural killer cells in children with autism.

Amanda M Enstrom1, Lisa Lit, Charity E Onore, Jeff P Gregg, Robin L Hansen, Isaac N Pessah, Irva Hertz-Picciotto, Judy A Van de Water, Frank R Sharp, Paul Ashwood.   

Abstract

Immune related abnormalities have repeatedly been reported in autism spectrum disorders (ASD), including evidence of immune dysregulation and autoimmune phenomena. NK cells may play an important role in neurodevelopmental disorders such as ASD. Here we performed a gene expression screen and cellular functional analysis on peripheral blood obtained from 52 children with ASD and 27 typically developing control children enrolled in the case-control CHARGE study. RNA expression of NK cell receptors and effector molecules were significantly upregulated in ASD. Flow cytometric analysis of NK cells demonstrated increased production of perforin, granzyme B, and interferon gamma (IFNgamma) under resting conditions in children with ASD (p<0.01). Following NK cell stimulation in the presence of K562 target cells, the cytotoxicity of NK cells was significantly reduced in ASD compared with controls (p<0.02). Furthermore, under similar stimulation conditions the presence of perforin, granzyme B, and IFNgamma in NK cells from ASD children was significantly lower compared with controls (p<0.001). These findings suggest possible dysfunction of NK cells in children with ASD. Abnormalities in NK cells may represent a susceptibility factor in ASD and may predispose to the development of autoimmunity and/or adverse neuroimmune interactions during critical periods of development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18762240      PMCID: PMC2636576          DOI: 10.1016/j.bbi.2008.08.001

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  77 in total

Review 1.  Molecular genetics of autism spectrum disorder.

Authors:  J Veenstra-VanderWeele; E H Cook
Journal:  Mol Psychiatry       Date:  2004-09       Impact factor: 15.992

2.  Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset.

Authors:  Aliz Barakonyi; Magali Rabot; Anne Marie-Cardine; Maryse Aguerre-Girr; Beata Polgar; Valérie Schiavon; Armand Bensussan; Philippe Le Bouteiller
Journal:  J Immunol       Date:  2004-11-01       Impact factor: 5.422

3.  Antibrain antibodies in infantile autism.

Authors:  R D Todd; J M Hickok; G M Anderson; D J Cohen
Journal:  Biol Psychiatry       Date:  1988-03-15       Impact factor: 13.382

4.  Early medical history of children with autism spectrum disorders.

Authors:  Rebecca Niehus; Catherine Lord
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

5.  Reduced natural killer cell activity in autism.

Authors:  R P Warren; A Foster; N C Margaretten
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1987-05       Impact factor: 8.829

6.  The Autism Diagnostic Observation Schedule: revised algorithms for improved diagnostic validity.

Authors:  Katherine Gotham; Susan Risi; Andrew Pickles; Catherine Lord
Journal:  J Autism Dev Disord       Date:  2006-12-16

7.  Increased frequency of the null allele at the complement C4b locus in autism.

Authors:  R P Warren; V K Singh; P Cole; J D Odell; C B Pingree; W L Warren; E White
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

8.  A role for interferon-gamma in focal cerebral ischemia in mice.

Authors:  Kate Lykke Lambertsen; Rikke Gregersen; Michael Meldgaard; Bettina Hjelm Clausen; Eva Kildall Heibøl; Rune Ladeby; Jens Knudsen; Aase Frandsen; Trevor Owens; Bente Finsen
Journal:  J Neuropathol Exp Neurol       Date:  2004-09       Impact factor: 3.685

9.  Modelling KIR-HLA genotype disparities in type 1 diabetes.

Authors:  A R van der Slik; B Z Alizadeh; B P C Koeleman; B O Roep; M J Giphart
Journal:  Tissue Antigens       Date:  2007-04

10.  Immune abnormalities in patients with autism.

Authors:  R P Warren; N C Margaretten; N C Pace; A Foster
Journal:  J Autism Dev Disord       Date:  1986-06
View more
  101 in total

1.  Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13.

Authors:  Zuzana Tobiasova; Klaas H B van der Lingen; Lawrence Scahill; James F Leckman; Yan Zhang; Wookjin Chae; James T McCracken; Christopher J McDougle; Benedetto Vitiello; Elaine Tierney; Michael G Aman; L Eugene Arnold; Liliya Katsovich; Pieter J Hoekstra; Fred Volkmar; Alfred L M Bothwell; Ivana Kawikova
Journal:  J Child Adolesc Psychopharmacol       Date:  2011-11-09       Impact factor: 2.576

2.  Integrative gene network analysis provides novel regulatory relationships, genetic contributions and susceptible targets in autism spectrum disorders.

Authors:  Tin-Lap Lee; Margarita J Raygada; Owen M Rennert
Journal:  Gene       Date:  2012-01-26       Impact factor: 3.688

Review 3.  Improving the prediction of response to therapy in autism.

Authors:  Stephen Bent; Robert L Hendren
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

4.  Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.

Authors:  Marjannie Eloi Akintunde; Melissa Rose; Paula Krakowiak; Luke Heuer; Paul Ashwood; Robin Hansen; Irva Hertz-Picciotto; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2015-07-11       Impact factor: 3.478

Review 5.  Beyond the brain: A multi-system inflammatory subtype of autism spectrum disorder.

Authors:  Robyn P Thom; Christopher J Keary; Michelle L Palumbo; Caitlin T Ravichandran; Jennifer E Mullett; Eric P Hazen; Ann M Neumeyer; Christopher J McDougle
Journal:  Psychopharmacology (Berl)       Date:  2019-05-28       Impact factor: 4.530

6.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2010-11-20       Impact factor: 3.478

7.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

8.  Comorbidity clusters in autism spectrum disorders: an electronic health record time-series analysis.

Authors:  Finale Doshi-Velez; Yaorong Ge; Isaac Kohane
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

Review 9.  Inflammatory profiles in the BTBR mouse: how relevant are they to autism spectrum disorders?

Authors:  Milo Careaga; Jared Schwartzer; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2014-06-14       Impact factor: 7.217

10.  The human placenta methylome.

Authors:  Diane I Schroeder; John D Blair; Paul Lott; Hung On Ken Yu; Danna Hong; Florence Crary; Paul Ashwood; Cheryl Walker; Ian Korf; Wendy P Robinson; Janine M LaSalle
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.